• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻喉癌患者中第二原发性癌症的表现。

Presentation of second primary cancers in young laryngeal carcinoma patients.

作者信息

Silén Suvi, Haapaniemi Aaro, Dickinson Amy, Rönn Karin, Mäkitie Antti

机构信息

a Department of Otorhinolaryngology - Head and Neck Surgery , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.

b Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences , Intervention and Technology, Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.

出版信息

Acta Otolaryngol. 2019 Jan;139(1):85-89. doi: 10.1080/00016489.2018.1527037. Epub 2019 Feb 3.

DOI:10.1080/00016489.2018.1527037
PMID:30712430
Abstract

BACKGROUND

Laryngeal squamous cell carcinoma (LSCC) is rare in the young.

OBJECTIVES

We characterized the clinical behavior of LSCC and assessed the presentation of second primary tumors (SPCs) in this patient population.

MATERIALS AND METHODS

Data from the Finnish Cancer Registry (FCR) were used to identify an epidemiological series of LSCC patients diagnosed at the age of 40 years or under, during 1953-2012 in Finland. Data regarding primary treatment, survival, and SPCs were available. To further characterize the comorbidity and lifestyle factors of young patients with LSCC, institutional data were collected of patients treated at the Helsinki University Hospital during 1967-2012.

RESULTS

We identified 151 patients, with a mean follow-up of 252 months. The 10-year overall survival (OS) was 75% and the disease-specific survival was 84%. SPCs were diagnosed in 26% (n = 39), with a median delay of 28 years. Of the 35 patients in the institutional series from Helsinki, 22 (63%) were current or former smokers. LSCC recurred in 28% of patients.

CONCLUSIONS AND SIGNIFICANCE

The delay to SPCs in young patients was significantly longer compared with the general LSCC population. As factors underlying this phenomenon cannot be identified by this retrospective study, further studies are warranted.

摘要

背景

喉鳞状细胞癌(LSCC)在年轻人中较为罕见。

目的

我们对LSCC的临床行为进行了特征描述,并评估了该患者群体中第二原发性肿瘤(SPC)的表现。

材料与方法

利用芬兰癌症登记处(FCR)的数据,确定了1953 - 2012年期间在芬兰诊断出的40岁及以下LSCC患者的流行病学系列。可获得有关初次治疗、生存情况和SPC的数据。为了进一步描述年轻LSCC患者的合并症和生活方式因素,收集了1967 - 2012年期间在赫尔辛基大学医院接受治疗的患者的机构数据。

结果

我们确定了151例患者,平均随访252个月。10年总生存率(OS)为75%,疾病特异性生存率为84%。26%(n = 39)的患者被诊断出患有SPC,中位延迟时间为28年。在赫尔辛基机构系列中的35例患者中,22例(63%)为现吸烟者或既往吸烟者。28%的患者LSCC复发。

结论及意义

与一般LSCC人群相比,年轻患者发生SPC的延迟时间明显更长。由于这项回顾性研究无法确定这一现象的潜在因素,因此有必要进行进一步研究。

相似文献

1
Presentation of second primary cancers in young laryngeal carcinoma patients.年轻喉癌患者中第二原发性癌症的表现。
Acta Otolaryngol. 2019 Jan;139(1):85-89. doi: 10.1080/00016489.2018.1527037. Epub 2019 Feb 3.
2
Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years.喉鳞状细胞癌患者即使在 20 年后仍有发生第二原发癌的显著风险。
Acta Oncol. 2023 Oct;62(10):1322-1330. doi: 10.1080/0284186X.2023.2254482. Epub 2023 Sep 6.
3
Impact of stage, management and recurrence on survival rates in laryngeal cancer.分期、治疗及复发对喉癌生存率的影响
PLoS One. 2017 Jul 14;12(7):e0179371. doi: 10.1371/journal.pone.0179371. eCollection 2017.
4
Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.对659例接受开放性喉功能保留手术治疗的喉鳞状细胞癌患者进行回顾性分析。
Acta Otolaryngol. 2018 Nov;138(11):1043-1050. doi: 10.1080/00016489.2018.1500711.
5
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
6
Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome.舌癌和喉癌鳞状细胞癌中的第二原发性恶性肿瘤:发病率、模式及转归分析
J Chin Med Assoc. 2008 Feb;71(2):86-91. doi: 10.1016/S1726-4901(08)70080-7.
7
Impact of patient and professional diagnostic delays on the risk of recurrence in laryngeal carcinoma.患者及专业诊断延迟对喉癌复发风险的影响。
Clin Otolaryngol. 2005 Apr;30(2):157-63. doi: 10.1111/j.1365-2273.2004.00954.x.
8
Development of comprehensive nomograms for evaluating overall and cancer-specific survival of laryngeal squamous cell carcinoma patients treated with neck dissection.用于评估接受颈部清扫术治疗的喉鳞状细胞癌患者总生存期和癌症特异性生存期的综合列线图的开发。
Oncotarget. 2017 May 2;8(18):29722-29740. doi: 10.18632/oncotarget.15414.
9
Management of T3N0M0 glottic carcinoma: therapeutic outcomes.T3N0M0声门癌的治疗:治疗结果
Laryngoscope. 2002 Jul;112(7 Pt 1):1281-8. doi: 10.1097/00005537-200207000-00026.
10
Low expression of nuclear Toll-like receptor 4 in laryngeal papillomas transforming into squamous cell carcinoma.喉乳头状瘤向鳞状细胞癌转变过程中核内Toll样受体4的低表达
Otolaryngol Head Neck Surg. 2014 Nov;151(5):785-90. doi: 10.1177/0194599814549730. Epub 2014 Sep 9.

引用本文的文献

1
Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.头颈部鳞状细胞癌患者发生第二原发性癌症的风险:一项系统评价和荟萃分析。
Clin Oral Investig. 2023 Sep;27(9):4897-4910. doi: 10.1007/s00784-023-05066-3. Epub 2023 Aug 4.
2
The risk of second primary cancer after nasopharyngeal cancer: a systematic review.鼻咽癌后第二原发癌的风险:系统评价。
Eur Arch Otorhinolaryngol. 2023 Nov;280(11):4775-4781. doi: 10.1007/s00405-023-08144-0. Epub 2023 Jul 26.
3
Prognostic factors of patients with initially diagnosed T1a glottic cancer: Novel nomograms and a propensity-score matched cohort analysis.
初诊为T1a期声门癌患者的预后因素:新型列线图与倾向评分匹配队列分析
Medicine (Baltimore). 2020 Nov 6;99(45):e23004. doi: 10.1097/MD.0000000000023004.